197 related articles for article (PubMed ID: 21443523)
1. Amphetamine augments action potential-dependent dopaminergic signaling in the striatum in vivo.
Ramsson ES; Covey DP; Daberkow DP; Litherland MT; Juliano SA; Garris PA
J Neurochem; 2011 Jun; 117(6):937-48. PubMed ID: 21443523
[TBL] [Abstract][Full Text] [Related]
2. High doses of amphetamine augment, rather than disrupt, exocytotic dopamine release in the dorsal and ventral striatum of the anesthetized rat.
Ramsson ES; Howard CD; Covey DP; Garris PA
J Neurochem; 2011 Dec; 119(6):1162-72. PubMed ID: 21806614
[TBL] [Abstract][Full Text] [Related]
3. Amphetamine augments vesicular dopamine release in the dorsal and ventral striatum through different mechanisms.
Avelar AJ; Juliano SA; Garris PA
J Neurochem; 2013 May; 125(3):373-85. PubMed ID: 23406303
[TBL] [Abstract][Full Text] [Related]
4. Amphetamine paradoxically augments exocytotic dopamine release and phasic dopamine signals.
Daberkow DP; Brown HD; Bunner KD; Kraniotis SA; Doellman MA; Ragozzino ME; Garris PA; Roitman MF
J Neurosci; 2013 Jan; 33(2):452-63. PubMed ID: 23303926
[TBL] [Abstract][Full Text] [Related]
5. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores.
Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1986 Apr; 237(1):193-203. PubMed ID: 3007738
[TBL] [Abstract][Full Text] [Related]
6. Amphetamine elicits opposing actions on readily releasable and reserve pools for dopamine.
Covey DP; Juliano SA; Garris PA
PLoS One; 2013; 8(5):e60763. PubMed ID: 23671560
[TBL] [Abstract][Full Text] [Related]
7. The blocking of kappa-opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization.
Azocar VH; Sepúlveda G; Ruiz C; Aguilera C; Andrés ME; Fuentealba JA
J Neurochem; 2019 Feb; 148(3):348-358. PubMed ID: 30315655
[TBL] [Abstract][Full Text] [Related]
8. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter.
Jones SR; Gainetdinov RR; Wightman RM; Caron MG
J Neurosci; 1998 Mar; 18(6):1979-86. PubMed ID: 9482784
[TBL] [Abstract][Full Text] [Related]
10. Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores.
Schmitz Y; Lee CJ; Schmauss C; Gonon F; Sulzer D
J Neurosci; 2001 Aug; 21(16):5916-24. PubMed ID: 11487614
[TBL] [Abstract][Full Text] [Related]
11. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.
Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
J Neurochem; 1988 Feb; 50(2):346-55. PubMed ID: 2447237
[TBL] [Abstract][Full Text] [Related]
12. Influence of chronic exercise on the amphetamine-induced dopamine release and neurodegeneration in the striatum of the rat.
Marques E; Vasconcelos F; Rolo MR; Pereira FC; Silva AP; Macedo TR; Ribeiro CF
Ann N Y Acad Sci; 2008 Oct; 1139():222-31. PubMed ID: 18991868
[TBL] [Abstract][Full Text] [Related]
13. Methamphetamine neurotoxicity decreases phasic, but not tonic, dopaminergic signaling in the rat striatum.
Howard CD; Keefe KA; Garris PA; Daberkow DP
J Neurochem; 2011 Aug; 118(4):668-76. PubMed ID: 21668447
[TBL] [Abstract][Full Text] [Related]
14. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
[TBL] [Abstract][Full Text] [Related]
15. Membrane-permeable C-terminal dopamine transporter peptides attenuate amphetamine-evoked dopamine release.
Rickhag M; Owens WA; Winkler MT; Strandfelt KN; Rathje M; Sørensen G; Andresen B; Madsen KL; Jørgensen TN; Wörtwein G; Woldbye DPD; Sitte H; Daws LC; Gether U
J Biol Chem; 2013 Sep; 288(38):27534-27544. PubMed ID: 23884410
[TBL] [Abstract][Full Text] [Related]
16. The long-term effects of repeated amphetamine treatment in vivo on amphetamine, KCl and electrical stimulation evoked striatal dopamine release in vitro.
Castañeda E; Becker JB; Robinson TE
Life Sci; 1988; 42(24):2447-56. PubMed ID: 3374264
[TBL] [Abstract][Full Text] [Related]
17. Reserpine enhances amphetamine stereotypies without increasing amphetamine-induced changes in striatal dialysate dopamine.
Callaway CW; Kuczenski R; Segal DS
Brain Res; 1989 Dec; 505(1):83-90. PubMed ID: 2611681
[TBL] [Abstract][Full Text] [Related]
18. Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine.
Williams JM; Owens WA; Turner GH; Saunders C; Dipace C; Blakely RD; France CP; Gore JC; Daws LC; Avison MJ; Galli A
PLoS Biol; 2007 Oct; 5(10):e274. PubMed ID: 17941718
[TBL] [Abstract][Full Text] [Related]
19. Biphasic mechanisms of amphetamine action at the dopamine terminal.
Siciliano CA; Calipari ES; Ferris MJ; Jones SR
J Neurosci; 2014 Apr; 34(16):5575-82. PubMed ID: 24741047
[TBL] [Abstract][Full Text] [Related]
20. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA
J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
